<DOC>
	<DOC>NCT01059539</DOC>
	<brief_summary>The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with bipolar I disorder.</brief_summary>
	<brief_title>Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<criteria>Patients who have provided informed consent prior to any study specific procedures Patients currently meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIVTR) criteria for bipolar I disorder as confirmed by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID) Patients who experienced a manic or mixed episode that required treatment within the past 12 months Patients with normal physical examination, laboratory, vital signs, and electrocardiogram (ECG) Patients with a DSMIVTR diagnosis of an axis I disorder other than bipolar I disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>mania</keyword>
	<keyword>acute mania</keyword>
	<keyword>bipolar I disorder</keyword>
</DOC>